Stablix, Inc.

Stablix, Inc. company information, Employees & Contact Information

Updated May 2026

Quick answer

Stablix, Inc. is a Biotechnology company. It has approximately 24 employees on record. Contact data was last refreshed in May 2026. Find Stablix, Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Co-located in New York City and Boston, we are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small-molecule modality for a wide variety of devastating diseases.
Looking for a particular Stablix, Inc. employee's phone or email?

Stablix, Inc. Questions

News

Stablix and Vertex Establish Strategic Collaboration to - GlobeNewswire

Stablix and Vertex Establish Strategic Collaboration to GlobeNewswire

Stablix Appoints Tony Kingsley as CEO - citybiz

Stablix Appoints Tony Kingsley as CEO citybiz

Stablix lands on stable footing with $63M series A for protein stabilization efforts - Fierce Biotech

Stablix lands on stable footing with $63M series A for protein stabilization efforts Fierce Biotech

Firm Advises Versant Ventures and NEA in Stablix’s $63 Million Series A Financing - Wilson Sonsini

Firm Advises Versant Ventures and NEA in Stablix’s $63 Million Series A Financing Wilson Sonsini

Stablix patents new PARP-1 inhibitors - BioWorld MedTech

Stablix patents new PARP-1 inhibitors BioWorld MedTech

Stablix, Vertex partner to develop targeted protein stabilisation therapies - Pharmaceutical Business review -

Stablix, Vertex partner to develop targeted protein stabilisation therapies Pharmaceutical Business review -

Indivior Appoints Tony Kingsley to the Board of Directors - PR Newswire

Indivior Appoints Tony Kingsley to the Board of Directors PR Newswire

Stablix Therapeutics Launches with $63 Million Series A Financing - Business Wire

Stablix Therapeutics Launches with $63 Million Series A Financing Business Wire

Fierce Biotech's 2021 Fierce 15 - Fierce Biotech

Fierce Biotech's 2021 Fierce 15 Fierce Biotech

Top Stablix, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant